

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.52797867 |
| 2 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.49329402 |
| 3 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.39131923 |
| 4 | axon ensheathment in central nervous system (GO:0032291) | 5.15290210 |
| 5 | central nervous system myelination (GO:0022010) | 5.15290210 |
| 6 | vocalization behavior (GO:0071625) | 5.14240395 |
| 7 | synaptic vesicle exocytosis (GO:0016079) | 5.02602261 |
| 8 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.00929878 |
| 9 | protein localization to synapse (GO:0035418) | 4.91322988 |
| 10 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.89969067 |
| 11 | locomotory exploration behavior (GO:0035641) | 4.80111312 |
| 12 | synaptic vesicle maturation (GO:0016188) | 4.79408912 |
| 13 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.59505609 |
| 14 | glutamate secretion (GO:0014047) | 4.57916582 |
| 15 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.57652997 |
| 16 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.57298315 |
| 17 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.54552575 |
| 18 | neuronal action potential propagation (GO:0019227) | 4.51104698 |
| 19 | glutamate receptor signaling pathway (GO:0007215) | 4.49782049 |
| 20 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.49620922 |
| 21 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.43388102 |
| 22 | neuron-neuron synaptic transmission (GO:0007270) | 4.30435971 |
| 23 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.27914625 |
| 24 | neuron cell-cell adhesion (GO:0007158) | 4.26593671 |
| 25 | synaptic transmission, glutamatergic (GO:0035249) | 4.22820310 |
| 26 | regulation of synaptic vesicle transport (GO:1902803) | 4.20112240 |
| 27 | regulation of synapse structural plasticity (GO:0051823) | 4.19162558 |
| 28 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.13886785 |
| 29 | exploration behavior (GO:0035640) | 4.12305104 |
| 30 | gamma-aminobutyric acid transport (GO:0015812) | 4.11817541 |
| 31 | positive regulation of synapse maturation (GO:0090129) | 4.08886808 |
| 32 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.97217381 |
| 33 | long-term memory (GO:0007616) | 3.91554904 |
| 34 | long-term synaptic potentiation (GO:0060291) | 3.90461039 |
| 35 | regulation of synaptic plasticity (GO:0048167) | 3.89231745 |
| 36 | regulation of postsynaptic membrane potential (GO:0060078) | 3.83517292 |
| 37 | response to histamine (GO:0034776) | 3.82817308 |
| 38 | synaptic transmission, dopaminergic (GO:0001963) | 3.82812454 |
| 39 | neurotransmitter secretion (GO:0007269) | 3.76940104 |
| 40 | regulation of female receptivity (GO:0045924) | 3.75444055 |
| 41 | positive regulation of membrane potential (GO:0045838) | 3.74779257 |
| 42 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.74577428 |
| 43 | sodium ion export (GO:0071436) | 3.73928526 |
| 44 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.72423342 |
| 45 | behavioral response to cocaine (GO:0048148) | 3.63234474 |
| 46 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.62645761 |
| 47 | behavioral defense response (GO:0002209) | 3.61014442 |
| 48 | behavioral fear response (GO:0001662) | 3.61014442 |
| 49 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.58857874 |
| 50 | potassium ion import (GO:0010107) | 3.54700912 |
| 51 | neuromuscular synaptic transmission (GO:0007274) | 3.52607718 |
| 52 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.51953912 |
| 53 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.51516950 |
| 54 | neuron recognition (GO:0008038) | 3.51475422 |
| 55 | long term synaptic depression (GO:0060292) | 3.50719585 |
| 56 | dendritic spine morphogenesis (GO:0060997) | 3.49981403 |
| 57 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.49952412 |
| 58 | regulation of dendritic spine development (GO:0060998) | 3.48912926 |
| 59 | regulation of glutamate secretion (GO:0014048) | 3.48775321 |
| 60 | membrane depolarization during action potential (GO:0086010) | 3.46479328 |
| 61 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.45437480 |
| 62 | female mating behavior (GO:0060180) | 3.43238629 |
| 63 | postsynaptic membrane organization (GO:0001941) | 3.38021348 |
| 64 | fear response (GO:0042596) | 3.35846633 |
| 65 | positive regulation of neurotransmitter transport (GO:0051590) | 3.35070989 |
| 66 | presynaptic membrane assembly (GO:0097105) | 3.34416849 |
| 67 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.33865142 |
| 68 | transmission of nerve impulse (GO:0019226) | 3.33650727 |
| 69 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.32791276 |
| 70 | response to amphetamine (GO:0001975) | 3.29699302 |
| 71 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.28450955 |
| 72 | detection of calcium ion (GO:0005513) | 3.28417863 |
| 73 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.26923762 |
| 74 | layer formation in cerebral cortex (GO:0021819) | 3.26533638 |
| 75 | regulation of vesicle fusion (GO:0031338) | 3.26330042 |
| 76 | synaptic vesicle endocytosis (GO:0048488) | 3.25957118 |
| 77 | dendritic spine organization (GO:0097061) | 3.25637172 |
| 78 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.25635680 |
| 79 | positive regulation of dendritic spine development (GO:0060999) | 3.21936126 |
| 80 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.20783265 |
| 81 | learning (GO:0007612) | 3.17003548 |
| 82 | axonal fasciculation (GO:0007413) | 3.16960982 |
| 83 | membrane depolarization (GO:0051899) | 3.16551055 |
| 84 | striatum development (GO:0021756) | 3.15029916 |
| 85 | regulation of neurotransmitter secretion (GO:0046928) | 3.14792915 |
| 86 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.14252672 |
| 87 | cellular potassium ion homeostasis (GO:0030007) | 3.13236662 |
| 88 | potassium ion homeostasis (GO:0055075) | 3.12855489 |
| 89 | regulation of synapse maturation (GO:0090128) | 3.12319392 |
| 90 | activation of protein kinase A activity (GO:0034199) | 3.11754161 |
| 91 | presynaptic membrane organization (GO:0097090) | 3.09715560 |
| 92 | positive regulation of synaptic transmission (GO:0050806) | 3.06239622 |
| 93 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.05720457 |
| 94 | prepulse inhibition (GO:0060134) | 3.04722886 |
| 95 | neuromuscular process controlling balance (GO:0050885) | 3.04019329 |
| 96 | cerebellar granule cell differentiation (GO:0021707) | 3.03961061 |
| 97 | auditory behavior (GO:0031223) | 3.03593884 |
| 98 | neurotransmitter transport (GO:0006836) | 3.02487305 |
| 99 | L-amino acid import (GO:0043092) | 3.02226116 |
| 100 | behavioral response to nicotine (GO:0035095) | 3.01665425 |
| 101 | regulation of synaptic transmission (GO:0050804) | 3.00559724 |
| 102 | innervation (GO:0060384) | 2.99898148 |
| 103 | startle response (GO:0001964) | 2.99536630 |
| 104 | dopamine receptor signaling pathway (GO:0007212) | 2.98381137 |
| 105 | regulation of neurotransmitter transport (GO:0051588) | 2.97113839 |
| 106 | vesicle transport along microtubule (GO:0047496) | 2.95356509 |
| 107 | neuronal ion channel clustering (GO:0045161) | 2.94916096 |
| 108 | synaptic transmission (GO:0007268) | 2.94878517 |
| 109 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.94680626 |
| 110 | neurotransmitter uptake (GO:0001504) | 2.91100571 |
| 111 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.91041164 |
| 112 | positive regulation of vesicle fusion (GO:0031340) | 2.90845845 |
| 113 | negative regulation of amino acid transport (GO:0051956) | 2.89759135 |
| 114 | regulation of neurotransmitter levels (GO:0001505) | 2.88782548 |
| 115 | proline transport (GO:0015824) | 2.87513105 |
| 116 | establishment of mitochondrion localization (GO:0051654) | 2.86840584 |
| 117 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.85980933 |
| 118 | adult walking behavior (GO:0007628) | 2.84095873 |
| 119 | cellular sodium ion homeostasis (GO:0006883) | 2.82705357 |
| 120 | response to auditory stimulus (GO:0010996) | 2.74949562 |
| 121 | regulation of cell communication by electrical coupling (GO:0010649) | 2.73193579 |
| 122 | amino acid import (GO:0043090) | 2.70888740 |
| 123 | mechanosensory behavior (GO:0007638) | 2.70337437 |
| 124 | cell communication by electrical coupling (GO:0010644) | 2.69184999 |
| 125 | cell migration in hindbrain (GO:0021535) | 2.68655577 |
| 126 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.66300504 |
| 127 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.65713572 |
| 128 | neuronal action potential (GO:0019228) | 2.64354650 |
| 129 | serotonin metabolic process (GO:0042428) | 2.63386653 |
| 130 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.62655841 |
| 131 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.62217292 |
| 132 | primary amino compound metabolic process (GO:1901160) | 2.62189384 |
| 133 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.60613271 |
| 134 | glycosphingolipid biosynthetic process (GO:0006688) | 2.58083145 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.06680302 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.62814178 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.29290541 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.22209536 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.18902280 |
| 6 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.83822388 |
| 7 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.79221443 |
| 8 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.78450510 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.78219807 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.78219807 |
| 11 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.68893215 |
| 12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.65975522 |
| 13 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.59432285 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.59044899 |
| 15 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.56462454 |
| 16 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.55935909 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.39363581 |
| 18 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.32261884 |
| 19 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.29662645 |
| 20 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.20783753 |
| 21 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.15197588 |
| 22 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.11974461 |
| 23 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.03201269 |
| 24 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.01875024 |
| 25 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.84435089 |
| 26 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.83239493 |
| 27 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.83044188 |
| 28 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.82607706 |
| 29 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.76576947 |
| 30 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.76282510 |
| 31 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.67482100 |
| 32 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.66295572 |
| 33 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.63903136 |
| 34 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.62939711 |
| 35 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.60168749 |
| 36 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.54375063 |
| 37 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.54306336 |
| 38 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.52356138 |
| 39 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.50302003 |
| 40 | P300_19829295_ChIP-Seq_ESCs_Human | 1.49949937 |
| 41 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.47480672 |
| 42 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.39494463 |
| 43 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.38352283 |
| 44 | VDR_22108803_ChIP-Seq_LS180_Human | 1.38012588 |
| 45 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.36965604 |
| 46 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.35058135 |
| 47 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.33010962 |
| 48 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.31892956 |
| 49 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.30771981 |
| 50 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.29673194 |
| 51 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.29281067 |
| 52 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.28523413 |
| 53 | AR_25329375_ChIP-Seq_VCAP_Human | 1.28386097 |
| 54 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.27138898 |
| 55 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.22940579 |
| 56 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.22028626 |
| 57 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.20896161 |
| 58 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.20766243 |
| 59 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.20431328 |
| 60 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20319104 |
| 61 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.18960644 |
| 62 | FUS_26573619_Chip-Seq_HEK293_Human | 1.18877854 |
| 63 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.18101237 |
| 64 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.14592240 |
| 65 | STAT3_23295773_ChIP-Seq_U87_Human | 1.14253775 |
| 66 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12607803 |
| 67 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.12483632 |
| 68 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.11974076 |
| 69 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.11787788 |
| 70 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.09992943 |
| 71 | AR_19668381_ChIP-Seq_PC3_Human | 1.08894518 |
| 72 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.08637669 |
| 73 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.08390144 |
| 74 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.06916531 |
| 75 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.05518747 |
| 76 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.03929330 |
| 77 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.02763315 |
| 78 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.01924745 |
| 79 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.01920658 |
| 80 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.01429405 |
| 81 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.99708984 |
| 82 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97832626 |
| 83 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97247854 |
| 84 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.97099978 |
| 85 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.96558062 |
| 86 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.95677151 |
| 87 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.95234713 |
| 88 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.94806574 |
| 89 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.94644464 |
| 90 | RXR_22108803_ChIP-Seq_LS180_Human | 0.94621385 |
| 91 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.93872964 |
| 92 | JUN_21703547_ChIP-Seq_K562_Human | 0.93431430 |
| 93 | TP53_16413492_ChIP-PET_HCT116_Human | 0.92509175 |
| 94 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.92284839 |
| 95 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.91765237 |
| 96 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.91750369 |
| 97 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.91316249 |
| 98 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.90860437 |
| 99 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.90737098 |
| 100 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.90534461 |
| 101 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.88904266 |
| 102 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.88265579 |
| 103 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.88160149 |
| 104 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.87715578 |
| 105 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.86895325 |
| 106 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.85777050 |
| 107 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.85544728 |
| 108 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85196489 |
| 109 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.85196489 |
| 110 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.84910640 |
| 111 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.84400317 |
| 112 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.83675861 |
| 113 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.83487614 |
| 114 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.83232149 |
| 115 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.83084955 |
| 116 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82453112 |
| 117 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.80433130 |
| 118 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.77870702 |
| 119 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.75562189 |
| 120 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.75273332 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.73330665 |
| 2 | MP0003880_abnormal_central_pattern | 5.29324465 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.18438601 |
| 4 | MP0002822_catalepsy | 3.75349432 |
| 5 | MP0004270_analgesia | 3.69832790 |
| 6 | MP0009745_abnormal_behavioral_response | 3.59715334 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.48138382 |
| 8 | MP0002064_seizures | 3.04979035 |
| 9 | MP0002572_abnormal_emotion/affect_behav | 2.88051374 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.76277033 |
| 11 | MP0009046_muscle_twitch | 2.59731977 |
| 12 | MP0002272_abnormal_nervous_system | 2.52830884 |
| 13 | MP0001501_abnormal_sleep_pattern | 2.50132607 |
| 14 | MP0001486_abnormal_startle_reflex | 2.32196157 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.25018385 |
| 16 | MP0002736_abnormal_nociception_after | 2.23119635 |
| 17 | MP0009780_abnormal_chondrocyte_physiolo | 2.13120301 |
| 18 | MP0001440_abnormal_grooming_behavior | 2.09957262 |
| 19 | MP0002909_abnormal_adrenal_gland | 1.99873764 |
| 20 | MP0003329_amyloid_beta_deposits | 1.97976617 |
| 21 | MP0005423_abnormal_somatic_nervous | 1.95096873 |
| 22 | MP0002735_abnormal_chemical_nociception | 1.91536512 |
| 23 | MP0002067_abnormal_sensory_capabilities | 1.81642197 |
| 24 | MP0002837_dystrophic_cardiac_calcinosis | 1.79851302 |
| 25 | MP0000751_myopathy | 1.74233307 |
| 26 | MP0001970_abnormal_pain_threshold | 1.68396612 |
| 27 | MP0003879_abnormal_hair_cell | 1.68105866 |
| 28 | MP0002733_abnormal_thermal_nociception | 1.68018506 |
| 29 | MP0001529_abnormal_vocalization | 1.66262052 |
| 30 | MP0002184_abnormal_innervation | 1.64044377 |
| 31 | MP0005386_behavior/neurological_phenoty | 1.63305450 |
| 32 | MP0004924_abnormal_behavior | 1.63305450 |
| 33 | MP0001188_hyperpigmentation | 1.61438160 |
| 34 | MP0004145_abnormal_muscle_electrophysio | 1.61422893 |
| 35 | MP0008569_lethality_at_weaning | 1.60714090 |
| 36 | MP0002557_abnormal_social/conspecific_i | 1.59785048 |
| 37 | MP0005646_abnormal_pituitary_gland | 1.59314506 |
| 38 | MP0001984_abnormal_olfaction | 1.58856240 |
| 39 | MP0004811_abnormal_neuron_physiology | 1.54902963 |
| 40 | MP0000778_abnormal_nervous_system | 1.53656485 |
| 41 | MP0001905_abnormal_dopamine_level | 1.42913629 |
| 42 | MP0006276_abnormal_autonomic_nervous | 1.41811295 |
| 43 | MP0000013_abnormal_adipose_tissue | 1.38165512 |
| 44 | MP0002066_abnormal_motor_capabilities/c | 1.33592690 |
| 45 | MP0000955_abnormal_spinal_cord | 1.29672788 |
| 46 | MP0001986_abnormal_taste_sensitivity | 1.27439768 |
| 47 | MP0004147_increased_porphyrin_level | 1.26885185 |
| 48 | MP0002638_abnormal_pupillary_reflex | 1.25308904 |
| 49 | MP0002882_abnormal_neuron_morphology | 1.23254657 |
| 50 | MP0004858_abnormal_nervous_system | 1.22772384 |
| 51 | MP0001502_abnormal_circadian_rhythm | 1.20940077 |
| 52 | MP0001485_abnormal_pinna_reflex | 1.18510517 |
| 53 | MP0003787_abnormal_imprinting | 1.14888186 |
| 54 | MP0003633_abnormal_nervous_system | 1.12133343 |
| 55 | MP0005645_abnormal_hypothalamus_physiol | 1.09854557 |
| 56 | MP0010234_abnormal_vibrissa_follicle | 1.09749521 |
| 57 | MP0003122_maternal_imprinting | 1.08052254 |
| 58 | MP0008877_abnormal_DNA_methylation | 1.07944264 |
| 59 | MP0004885_abnormal_endolymph | 1.07314908 |
| 60 | MP0010386_abnormal_urinary_bladder | 1.02074798 |
| 61 | MP0008874_decreased_physiological_sensi | 0.98818905 |
| 62 | MP0002653_abnormal_ependyma_morphology | 0.98261095 |
| 63 | MP0002069_abnormal_eating/drinking_beha | 0.98107484 |
| 64 | MP0003123_paternal_imprinting | 0.96170413 |
| 65 | MP0004215_abnormal_myocardial_fiber | 0.95433481 |
| 66 | MP0003631_nervous_system_phenotype | 0.94945152 |
| 67 | MP0003690_abnormal_glial_cell | 0.93836388 |
| 68 | MP0005535_abnormal_body_temperature | 0.92883816 |
| 69 | MP0004484_altered_response_of | 0.92829695 |
| 70 | MP0004085_abnormal_heartbeat | 0.91997603 |
| 71 | MP0002152_abnormal_brain_morphology | 0.91973765 |
| 72 | MP0005409_darkened_coat_color | 0.91078517 |
| 73 | MP0003075_altered_response_to | 0.90421800 |
| 74 | MP0008872_abnormal_physiological_respon | 0.87234056 |
| 75 | MP0002234_abnormal_pharynx_morphology | 0.86303632 |
| 76 | MP0004036_abnormal_muscle_relaxation | 0.84749366 |
| 77 | MP0004142_abnormal_muscle_tone | 0.83785552 |
| 78 | MP0000026_abnormal_inner_ear | 0.83342254 |
| 79 | MP0000747_muscle_weakness | 0.83304070 |
| 80 | MP0000749_muscle_degeneration | 0.83019360 |
| 81 | MP0003283_abnormal_digestive_organ | 0.82297069 |
| 82 | MP0001664_abnormal_digestion | 0.81800101 |
| 83 | MP0003646_muscle_fatigue | 0.81097699 |
| 84 | MP0000604_amyloidosis | 0.80413436 |
| 85 | MP0002876_abnormal_thyroid_physiology | 0.79753757 |
| 86 | MP0004133_heterotaxia | 0.78586374 |
| 87 | MP0004233_abnormal_muscle_weight | 0.78538111 |
| 88 | MP0005620_abnormal_muscle_contractility | 0.77638415 |
| 89 | MP0000569_abnormal_digit_pigmentation | 0.76282074 |
| 90 | MP0000566_synostosis | 0.76145931 |
| 91 | MP0001177_atelectasis | 0.74561347 |
| 92 | MP0002229_neurodegeneration | 0.74469131 |
| 93 | MP0005167_abnormal_blood-brain_barrier | 0.73450128 |
| 94 | MP0004130_abnormal_muscle_cell | 0.71827206 |
| 95 | MP0004742_abnormal_vestibular_system | 0.70986978 |
| 96 | MP0001963_abnormal_hearing_physiology | 0.68856406 |
| 97 | MP0000631_abnormal_neuroendocrine_gland | 0.68530924 |
| 98 | MP0005253_abnormal_eye_physiology | 0.66584807 |
| 99 | MP0002160_abnormal_reproductive_system | 0.65238808 |
| 100 | MP0005551_abnormal_eye_electrophysiolog | 0.64298795 |
| 101 | MP0001765_abnormal_ion_homeostasis | 0.64196023 |
| 102 | MP0005394_taste/olfaction_phenotype | 0.63202162 |
| 103 | MP0005499_abnormal_olfactory_system | 0.63202162 |
| 104 | MP0002752_abnormal_somatic_nervous | 0.62557014 |
| 105 | MP0004043_abnormal_pH_regulation | 0.62433405 |
| 106 | MP0004510_myositis | 0.61981966 |
| 107 | MP0002106_abnormal_muscle_physiology | 0.61897599 |
| 108 | MP0006292_abnormal_olfactory_placode | 0.60927242 |
| 109 | MP0000759_abnormal_skeletal_muscle | 0.60861735 |
| 110 | MP0003121_genomic_imprinting | 0.60846499 |
| 111 | MP0003137_abnormal_impulse_conducting | 0.60299042 |
| 112 | MP0006072_abnormal_retinal_apoptosis | 0.59334993 |
| 113 | MP0005187_abnormal_penis_morphology | 0.59083706 |
| 114 | MP0000920_abnormal_myelination | 0.59041680 |
| 115 | MP0002102_abnormal_ear_morphology | 0.58567550 |
| 116 | MP0003632_abnormal_nervous_system | 0.58172536 |
| 117 | MP0001346_abnormal_lacrimal_gland | 0.57166461 |
| 118 | MP0003634_abnormal_glial_cell | 0.54748389 |
| 119 | MP0002090_abnormal_vision | 0.54635890 |
| 120 | MP0005369_muscle_phenotype | 0.54050479 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.57186804 |
| 2 | Myokymia (HP:0002411) | 6.33763763 |
| 3 | Focal seizures (HP:0007359) | 5.71551100 |
| 4 | Atonic seizures (HP:0010819) | 5.16543537 |
| 5 | Epileptic encephalopathy (HP:0200134) | 5.10098190 |
| 6 | Visual hallucinations (HP:0002367) | 5.05650896 |
| 7 | Limb dystonia (HP:0002451) | 4.83603086 |
| 8 | Hyperventilation (HP:0002883) | 4.60709513 |
| 9 | Absence seizures (HP:0002121) | 4.54348649 |
| 10 | Febrile seizures (HP:0002373) | 4.42762830 |
| 11 | Dialeptic seizures (HP:0011146) | 4.24298023 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 3.88579682 |
| 13 | Broad-based gait (HP:0002136) | 3.76595703 |
| 14 | Poor eye contact (HP:0000817) | 3.47738681 |
| 15 | Anxiety (HP:0000739) | 3.24576077 |
| 16 | Amblyopia (HP:0000646) | 3.18076635 |
| 17 | Depression (HP:0000716) | 3.10063929 |
| 18 | Progressive cerebellar ataxia (HP:0002073) | 3.06513420 |
| 19 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.02539693 |
| 20 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.02539693 |
| 21 | Cerebral hypomyelination (HP:0006808) | 3.02024314 |
| 22 | Impaired social interactions (HP:0000735) | 3.01551610 |
| 23 | Abnormal social behavior (HP:0012433) | 3.01551610 |
| 24 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.93635066 |
| 25 | Cerebral inclusion bodies (HP:0100314) | 2.91796490 |
| 26 | Abnormality of the corticospinal tract (HP:0002492) | 2.89014268 |
| 27 | Gaze-evoked nystagmus (HP:0000640) | 2.88955334 |
| 28 | Truncal ataxia (HP:0002078) | 2.88934136 |
| 29 | Excessive salivation (HP:0003781) | 2.87437676 |
| 30 | Drooling (HP:0002307) | 2.87437676 |
| 31 | Supranuclear gaze palsy (HP:0000605) | 2.87055216 |
| 32 | Fetal akinesia sequence (HP:0001989) | 2.84147502 |
| 33 | Dysmetria (HP:0001310) | 2.82017935 |
| 34 | Action tremor (HP:0002345) | 2.79564955 |
| 35 | Exercise-induced myalgia (HP:0003738) | 2.72324311 |
| 36 | Dysdiadochokinesis (HP:0002075) | 2.71685491 |
| 37 | Torticollis (HP:0000473) | 2.67388635 |
| 38 | Akinesia (HP:0002304) | 2.66975272 |
| 39 | Ankle clonus (HP:0011448) | 2.66675506 |
| 40 | Abnormality of the lower motor neuron (HP:0002366) | 2.56011452 |
| 41 | Stereotypic behavior (HP:0000733) | 2.52943953 |
| 42 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.50880585 |
| 43 | Epileptiform EEG discharges (HP:0011182) | 2.50250894 |
| 44 | Focal dystonia (HP:0004373) | 2.49113563 |
| 45 | Delusions (HP:0000746) | 2.45046901 |
| 46 | Abnormal eating behavior (HP:0100738) | 2.44877485 |
| 47 | Neurofibrillary tangles (HP:0002185) | 2.43843693 |
| 48 | Thickened helices (HP:0000391) | 2.35250686 |
| 49 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.34119031 |
| 50 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.30210337 |
| 51 | Absent speech (HP:0001344) | 2.29480514 |
| 52 | Inability to walk (HP:0002540) | 2.28513399 |
| 53 | Scanning speech (HP:0002168) | 2.26922268 |
| 54 | Annular pancreas (HP:0001734) | 2.26061257 |
| 55 | Craniofacial dystonia (HP:0012179) | 2.26016800 |
| 56 | EEG with generalized epileptiform discharges (HP:0011198) | 2.23761662 |
| 57 | Mutism (HP:0002300) | 2.20801739 |
| 58 | Progressive inability to walk (HP:0002505) | 2.20373167 |
| 59 | Hemiplegia (HP:0002301) | 2.17734542 |
| 60 | Bundle branch block (HP:0011710) | 2.16860943 |
| 61 | Calf muscle hypertrophy (HP:0008981) | 2.16614280 |
| 62 | Postural instability (HP:0002172) | 2.16268467 |
| 63 | Impaired smooth pursuit (HP:0007772) | 2.15981800 |
| 64 | Urinary urgency (HP:0000012) | 2.14284560 |
| 65 | Dysmetric saccades (HP:0000641) | 2.14106529 |
| 66 | Shoulder girdle muscle weakness (HP:0003547) | 2.12560969 |
| 67 | Bradykinesia (HP:0002067) | 2.11603418 |
| 68 | Myotonia (HP:0002486) | 2.11498516 |
| 69 | Generalized myoclonic seizures (HP:0002123) | 2.07668332 |
| 70 | CNS hypomyelination (HP:0003429) | 2.07576650 |
| 71 | Hemiparesis (HP:0001269) | 2.07453412 |
| 72 | Congenital stationary night blindness (HP:0007642) | 2.07263272 |
| 73 | Sleep apnea (HP:0010535) | 2.06965333 |
| 74 | Type II lissencephaly (HP:0007260) | 2.06401713 |
| 75 | Lower limb amyotrophy (HP:0007210) | 2.05742401 |
| 76 | Clonus (HP:0002169) | 2.02989319 |
| 77 | Hypsarrhythmia (HP:0002521) | 2.00981331 |
| 78 | Termporal pattern (HP:0011008) | 1.97992954 |
| 79 | Insidious onset (HP:0003587) | 1.97992954 |
| 80 | Medial flaring of the eyebrow (HP:0010747) | 1.97935619 |
| 81 | Resting tremor (HP:0002322) | 1.97134173 |
| 82 | Prolonged QT interval (HP:0001657) | 1.97110040 |
| 83 | Impaired vibratory sensation (HP:0002495) | 1.96167904 |
| 84 | Status epilepticus (HP:0002133) | 1.95862128 |
| 85 | Sudden death (HP:0001699) | 1.95401247 |
| 86 | Papilledema (HP:0001085) | 1.95301788 |
| 87 | Abnormality of the calf musculature (HP:0001430) | 1.93569360 |
| 88 | Rapidly progressive (HP:0003678) | 1.92610886 |
| 89 | Incomplete penetrance (HP:0003829) | 1.91757907 |
| 90 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.91171075 |
| 91 | Confusion (HP:0001289) | 1.89896392 |
| 92 | Ulnar claw (HP:0001178) | 1.89759360 |
| 93 | Abnormality of salivation (HP:0100755) | 1.89690245 |
| 94 | Megalencephaly (HP:0001355) | 1.88336191 |
| 95 | Blue irides (HP:0000635) | 1.86913935 |
| 96 | Protruding tongue (HP:0010808) | 1.86866985 |
| 97 | Abnormality of binocular vision (HP:0011514) | 1.86266402 |
| 98 | Diplopia (HP:0000651) | 1.86266402 |
| 99 | Spastic gait (HP:0002064) | 1.85468831 |
| 100 | Molar tooth sign on MRI (HP:0002419) | 1.84554989 |
| 101 | Abnormality of midbrain morphology (HP:0002418) | 1.84554989 |
| 102 | Abnormal EKG (HP:0003115) | 1.84406629 |
| 103 | Dyskinesia (HP:0100660) | 1.83659809 |
| 104 | Choreoathetosis (HP:0001266) | 1.82807980 |
| 105 | Psychosis (HP:0000709) | 1.82684635 |
| 106 | Pancreatic fibrosis (HP:0100732) | 1.82306254 |
| 107 | Spastic tetraplegia (HP:0002510) | 1.80738067 |
| 108 | Rigidity (HP:0002063) | 1.80728419 |
| 109 | Nephronophthisis (HP:0000090) | 1.80638695 |
| 110 | Gait imbalance (HP:0002141) | 1.80319331 |
| 111 | Diminished movement (HP:0002374) | 1.80136406 |
| 112 | Hypoventilation (HP:0002791) | 1.80018108 |
| 113 | True hermaphroditism (HP:0010459) | 1.79968161 |
| 114 | Unsteady gait (HP:0002317) | 1.79910001 |
| 115 | Deep palmar crease (HP:0006191) | 1.79644685 |
| 116 | Ankyloglossia (HP:0010296) | 1.78786486 |
| 117 | Intention tremor (HP:0002080) | 1.77089333 |
| 118 | Distal lower limb amyotrophy (HP:0008944) | 1.76966156 |
| 119 | Spastic tetraparesis (HP:0001285) | 1.76294768 |
| 120 | Ventricular fibrillation (HP:0001663) | 1.74070315 |
| 121 | Heart block (HP:0012722) | 1.73909282 |
| 122 | Lower limb muscle weakness (HP:0007340) | 1.73300484 |
| 123 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.72923869 |
| 124 | Syncope (HP:0001279) | 1.71854856 |
| 125 | Pheochromocytoma (HP:0002666) | 1.71640500 |
| 126 | Gait ataxia (HP:0002066) | 1.70479202 |
| 127 | Pancreatic cysts (HP:0001737) | 1.69161269 |
| 128 | Genetic anticipation (HP:0003743) | 1.68702330 |
| 129 | Obstructive sleep apnea (HP:0002870) | 1.67928272 |
| 130 | Muscular hypotonia of the trunk (HP:0008936) | 1.67241434 |
| 131 | Increased variability in muscle fiber diameter (HP:0003557) | 1.67213566 |
| 132 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.66663302 |
| 133 | Polyphagia (HP:0002591) | 1.66010359 |
| 134 | Decreased central vision (HP:0007663) | 1.65797234 |
| 135 | Specific learning disability (HP:0001328) | 1.65201565 |
| 136 | Increased circulating renin level (HP:0000848) | 1.64769656 |
| 137 | Lower limb asymmetry (HP:0100559) | 1.64525434 |
| 138 | Muscle fiber inclusion bodies (HP:0100299) | 1.64217381 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 6.18079990 |
| 2 | NTRK3 | 4.48820708 |
| 3 | MAP3K9 | 3.58047261 |
| 4 | KSR2 | 2.82946830 |
| 5 | DAPK2 | 2.69063392 |
| 6 | RIPK4 | 2.65661703 |
| 7 | CASK | 2.60336279 |
| 8 | ARAF | 2.44020925 |
| 9 | MAP3K4 | 2.30400409 |
| 10 | KSR1 | 2.26138072 |
| 11 | MAP3K13 | 2.21145483 |
| 12 | MINK1 | 2.20697285 |
| 13 | MAP3K12 | 2.08728070 |
| 14 | MAP2K7 | 2.02931863 |
| 15 | MAP2K4 | 1.86073162 |
| 16 | PRPF4B | 1.81142040 |
| 17 | DAPK1 | 1.79812809 |
| 18 | PLK2 | 1.77136915 |
| 19 | PAK6 | 1.67175586 |
| 20 | MARK1 | 1.57333022 |
| 21 | RAF1 | 1.53633797 |
| 22 | CAMKK1 | 1.52282866 |
| 23 | NTRK1 | 1.49092906 |
| 24 | PRKD3 | 1.48186632 |
| 25 | NTRK2 | 1.42786792 |
| 26 | GRK5 | 1.41786059 |
| 27 | PTK2B | 1.41742556 |
| 28 | CDK19 | 1.41646850 |
| 29 | CDK5 | 1.41361089 |
| 30 | CAMKK2 | 1.37125423 |
| 31 | BMPR2 | 1.32907930 |
| 32 | FRK | 1.31999050 |
| 33 | TNIK | 1.23359996 |
| 34 | NME1 | 1.22086095 |
| 35 | STK39 | 1.15591583 |
| 36 | WNK4 | 1.15469903 |
| 37 | MAP3K2 | 1.14058225 |
| 38 | FES | 1.12413271 |
| 39 | CAMK2A | 1.07313217 |
| 40 | PKN1 | 1.04987418 |
| 41 | PRKCG | 1.02699124 |
| 42 | CSNK1G3 | 1.01991150 |
| 43 | SIK2 | 1.01520599 |
| 44 | GRK1 | 1.00948874 |
| 45 | CAMK2B | 1.00547542 |
| 46 | LIMK1 | 0.95880640 |
| 47 | MUSK | 0.94562921 |
| 48 | MAP3K1 | 0.92914919 |
| 49 | PNCK | 0.91585648 |
| 50 | MAPK13 | 0.91568129 |
| 51 | BRAF | 0.89307146 |
| 52 | ADRBK2 | 0.86155652 |
| 53 | TYRO3 | 0.85681613 |
| 54 | STK38 | 0.84331135 |
| 55 | MOS | 0.84014258 |
| 56 | CAMK1 | 0.82812890 |
| 57 | CDK14 | 0.82247994 |
| 58 | CDK18 | 0.80974809 |
| 59 | PHKG2 | 0.80800680 |
| 60 | PHKG1 | 0.80800680 |
| 61 | PINK1 | 0.80796216 |
| 62 | CCNB1 | 0.80360962 |
| 63 | CSNK1G1 | 0.79411013 |
| 64 | FGFR2 | 0.77400290 |
| 65 | CDK15 | 0.76229857 |
| 66 | OXSR1 | 0.74566858 |
| 67 | CSNK1A1L | 0.71533814 |
| 68 | MAP2K1 | 0.70488850 |
| 69 | SGK494 | 0.69258755 |
| 70 | SGK223 | 0.69258755 |
| 71 | MAP2K6 | 0.67954567 |
| 72 | CDK11A | 0.65712968 |
| 73 | PDPK1 | 0.65509546 |
| 74 | BCKDK | 0.65343047 |
| 75 | SGK1 | 0.64398162 |
| 76 | TAOK1 | 0.64238102 |
| 77 | DYRK2 | 0.63953353 |
| 78 | PDK1 | 0.62057635 |
| 79 | UHMK1 | 0.61513909 |
| 80 | FGR | 0.61387356 |
| 81 | DYRK1A | 0.60290609 |
| 82 | FER | 0.60019234 |
| 83 | PAK3 | 0.58466960 |
| 84 | PRKCH | 0.57495866 |
| 85 | PIK3CA | 0.56536805 |
| 86 | CAMK2D | 0.56087169 |
| 87 | MAP4K2 | 0.55774386 |
| 88 | RET | 0.54515491 |
| 89 | SIK3 | 0.53368635 |
| 90 | PRKG1 | 0.53136709 |
| 91 | BCR | 0.52965389 |
| 92 | MAP3K7 | 0.52947469 |
| 93 | SGK2 | 0.52800653 |
| 94 | BMPR1B | 0.52715284 |
| 95 | MAPK12 | 0.52267777 |
| 96 | CSNK1A1 | 0.51039565 |
| 97 | STK11 | 0.50086981 |
| 98 | LATS2 | 0.49369830 |
| 99 | DAPK3 | 0.48572511 |
| 100 | PRKCE | 0.48353789 |
| 101 | AKT3 | 0.48241130 |
| 102 | MARK2 | 0.46701331 |
| 103 | INSRR | 0.46507100 |
| 104 | PRKCA | 0.46207166 |
| 105 | MAP3K11 | 0.44448615 |
| 106 | CSNK1G2 | 0.44228357 |
| 107 | CAMK2G | 0.43095567 |
| 108 | CSNK1D | 0.42797088 |
| 109 | LMTK2 | 0.41755596 |
| 110 | ADRBK1 | 0.41101289 |
| 111 | TIE1 | 0.41008740 |
| 112 | MAPK15 | 0.40563221 |
| 113 | ROCK1 | 0.38133180 |
| 114 | TNK2 | 0.37210032 |
| 115 | CSNK1E | 0.34753968 |
| 116 | RPS6KA3 | 0.34723267 |
| 117 | SGK3 | 0.34707948 |
| 118 | DMPK | 0.34557847 |
| 119 | NEK6 | 0.34483875 |
| 120 | PRKCZ | 0.32953774 |
| 121 | MAPKAPK5 | 0.31729890 |
| 122 | ROCK2 | 0.31429133 |
| 123 | FYN | 0.31228015 |
| 124 | CAMK4 | 0.30838887 |
| 125 | WNK3 | 0.30775076 |
| 126 | MAPK10 | 0.30376357 |
| 127 | PRKACA | 0.30322488 |
| 128 | OBSCN | 0.30287973 |
| 129 | CAMK1G | 0.28767903 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.75134917 |
| 2 | Olfactory transduction_Homo sapiens_hsa04740 | 3.03731832 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.96427697 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.94962715 |
| 5 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.79388072 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.77681834 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.75984566 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.55466927 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.54985054 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.50760733 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.25296453 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.19326546 |
| 13 | Renin secretion_Homo sapiens_hsa04924 | 1.96589422 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.95801470 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.93336475 |
| 16 | Long-term depression_Homo sapiens_hsa04730 | 1.89233364 |
| 17 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.85334535 |
| 18 | Taste transduction_Homo sapiens_hsa04742 | 1.82530904 |
| 19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.82495563 |
| 20 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.81773525 |
| 21 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.81638500 |
| 22 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.80992983 |
| 23 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.80044798 |
| 24 | Cocaine addiction_Homo sapiens_hsa05030 | 1.79735134 |
| 25 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.76166713 |
| 26 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.62176671 |
| 27 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.56605223 |
| 28 | Gap junction_Homo sapiens_hsa04540 | 1.38427165 |
| 29 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.34666430 |
| 30 | Histidine metabolism_Homo sapiens_hsa00340 | 1.31413768 |
| 31 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.27110776 |
| 32 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.23436710 |
| 33 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.21685732 |
| 34 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.20541406 |
| 35 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.20255365 |
| 36 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.19819963 |
| 37 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.19197167 |
| 38 | Glioma_Homo sapiens_hsa05214 | 1.15646753 |
| 39 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.15484496 |
| 40 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.14569817 |
| 41 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.12308388 |
| 42 | Melanogenesis_Homo sapiens_hsa04916 | 1.11280907 |
| 43 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.10697898 |
| 44 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.10500122 |
| 45 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.08545625 |
| 46 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.04897014 |
| 47 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.03319096 |
| 48 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.99378539 |
| 49 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.97778904 |
| 50 | Axon guidance_Homo sapiens_hsa04360 | 0.97432581 |
| 51 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.92884044 |
| 52 | Bile secretion_Homo sapiens_hsa04976 | 0.92537530 |
| 53 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.91066921 |
| 54 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.88721270 |
| 55 | Phototransduction_Homo sapiens_hsa04744 | 0.88455468 |
| 56 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.84827741 |
| 57 | Alzheimers disease_Homo sapiens_hsa05010 | 0.84183554 |
| 58 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.83494727 |
| 59 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81455181 |
| 60 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.80475548 |
| 61 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.79439794 |
| 62 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.77932272 |
| 63 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.76770560 |
| 64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.76748809 |
| 65 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.75073530 |
| 66 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.74036780 |
| 67 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.73539986 |
| 68 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.72517499 |
| 69 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.70976662 |
| 70 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.66755020 |
| 71 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.66510442 |
| 72 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.64905503 |
| 73 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.64855473 |
| 74 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.64652603 |
| 75 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.64047656 |
| 76 | Circadian rhythm_Homo sapiens_hsa04710 | 0.63717858 |
| 77 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.63458334 |
| 78 | Mineral absorption_Homo sapiens_hsa04978 | 0.62828538 |
| 79 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.62573197 |
| 80 | Sulfur relay system_Homo sapiens_hsa04122 | 0.60194323 |
| 81 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.59097032 |
| 82 | Parkinsons disease_Homo sapiens_hsa05012 | 0.56879106 |
| 83 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.55775668 |
| 84 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.55605824 |
| 85 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.53078231 |
| 86 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.52661243 |
| 87 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51981272 |
| 88 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.51445498 |
| 89 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.51007406 |
| 90 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.50907050 |
| 91 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49937919 |
| 92 | Alcoholism_Homo sapiens_hsa05034 | 0.49435721 |
| 93 | Prion diseases_Homo sapiens_hsa05020 | 0.49101172 |
| 94 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.49098854 |
| 95 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.46591638 |
| 96 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.46054779 |
| 97 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.44801638 |
| 98 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.44135923 |
| 99 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43990739 |
| 100 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43909070 |
| 101 | Peroxisome_Homo sapiens_hsa04146 | 0.43157894 |
| 102 | ABC transporters_Homo sapiens_hsa02010 | 0.42695874 |
| 103 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.41145041 |
| 104 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.40833388 |
| 105 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.40424756 |
| 106 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.38472724 |
| 107 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.36166957 |
| 108 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.36053394 |
| 109 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.36002001 |
| 110 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35760707 |
| 111 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.35102687 |
| 112 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35053564 |
| 113 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.34144360 |
| 114 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.33921032 |
| 115 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.33413318 |
| 116 | Tight junction_Homo sapiens_hsa04530 | 0.33190222 |
| 117 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.32915392 |
| 118 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.31528993 |
| 119 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.30464636 |
| 120 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.29634308 |
| 121 | Huntingtons disease_Homo sapiens_hsa05016 | 0.28437646 |
| 122 | Endocytosis_Homo sapiens_hsa04144 | 0.27918959 |
| 123 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.27635245 |
| 124 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.25155528 |
| 125 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.24681381 |
| 126 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.24455720 |
| 127 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.23544636 |
| 128 | Platelet activation_Homo sapiens_hsa04611 | 0.23174321 |
| 129 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.22470590 |
| 130 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22436779 |
| 131 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.21307295 |

